These pro-lipogenic alterations in HER2/neu-positive breast cancer cells are congruent with the observation that these cells possess higher levels of stored triacylglycerides (TAGs) as well as higher levels of saturated fatty acids compared to other cell types [6, 8]. This evidence concerns the gene ERBB2 and breast cancer.